ARROWHEAD PHARMACEUTICALS, INC. Amortization of Debt Discount (Premium)
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Amortization of Debt Discount (Premium) of $945.11 thousand for the 9-month period ending 2015-06-30, per its 10-Q filed 2015-08-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2015-08-04
- ARROWHEAD PHARMACEUTICALS, INC. amortization of debt discount (premium) for the quarter ending 2015-06-30 was $276.75K, a 88.29% increase year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. amortization of debt discount (premium) for the quarter ending 2015-03-31 was $320.66K, a 33.13% increase year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. amortization of debt discount (premium) for the quarter ending 2014-12-31 was $347.70K, a 1122.46% increase year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. amortization of debt discount (premium) for the quarter ending 2014-09-30 was $377.60K, a 719.70% increase year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. amortization of debt discount (premium) for fiscal 2014 was $793.89K, a 518.26% increase from fiscal 2013.
- ARROWHEAD PHARMACEUTICALS, INC. amortization of debt discount (premium) for fiscal 2013 was $128.41K, a 1267.48% increase from fiscal 2012.
- ARROWHEAD PHARMACEUTICALS, INC. amortization of debt discount (premium) for fiscal 2012 was $9.39K.
- ARROWHEAD PHARMACEUTICALS, INC. amortization of debt discount (premium) for fiscal 2011 was -$7.94K.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 9 month as first filed | Amortization of Debt Discount (Premium) 12 month | Amortization of Debt Discount (Premium) 98 month | Amortization of Debt Discount (Premium) 101 month | Amortization of Debt Discount (Premium) 104 month | Amortization of Debt Discount (Premium) 107 month | Amortization of Debt Discount (Premium) 110 month | Amortization of Debt Discount (Premium) 113 month | Amortization of Debt Discount (Premium) 116 month | Amortization of Debt Discount (Premium) 119 month | Amortization of Debt Discount (Premium) 122 month | Amortization of Debt Discount (Premium) 125 month | Amortization of Debt Discount (Premium) 128 month | Amortization of Debt Discount (Premium) 131 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015-06-30 | $276.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-04 | $597.41K derived: sum of 2 quarters · filed 2015-08-04 | $945.11K 10-Q · filed 2015-08-04 | $1.32M derived: sum of 4 quarters · filed 2015-08-04 | |||||||||||||
| 2015-03-31 | $320.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-11 | $668.36K 10-Q · filed 2015-05-11 | $1.05M derived: sum of 3 quarters · filed 2015-05-11 | $1.19M derived: sum of 4 quarters · filed 2015-08-04 | |||||||||||||
| 2014-12-31 | $347.70K 10-Q · filed 2015-02-09 | $725.30K derived: sum of 2 quarters · filed 2015-02-09 | $872.28K derived: sum of 3 quarters · filed 2015-08-04 | $1.11M derived: sum of 4 quarters · filed 2015-08-04 | |||||||||||||
| 2014-09-30 | $377.60K derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-25 | $524.57K derived: sum of 2 quarters · filed 2015-08-04 | $765.44K derived: sum of 3 quarters · filed 2015-08-04 | $793.89K 10-K · filed 2014-11-25 | |||||||||||||
| 2014-06-30 | $146.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-04 | $387.85K derived: sum of 2 quarters · filed 2015-08-04 | $416.29K 10-Q · filed 2015-08-04 | $416.29K 10-Q · filed 2014-08-12 | $462.36K derived: sum of 4 quarters · filed 2015-08-04 | ||||||||||||
| 2014-03-31 | $240.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-11 | $269.31K 10-Q · filed 2015-05-11 | $315.38K derived: sum of 3 quarters · filed 2015-05-11 | $360.79K derived: sum of 4 quarters · filed 2015-05-11 | $399.17K 10-Q · filed 2014-05-06 | ||||||||||||
| 2013-12-31 | $28.44K 10-Q · filed 2015-02-09 | $74.51K derived: sum of 2 quarters · filed 2015-02-09 | $119.92K derived: sum of 3 quarters · filed 2015-02-09 | $156.28K derived: sum of 4 quarters · filed 2015-02-09 | $158.30K 10-Q · filed 2014-02-04 | ||||||||||||
| 2013-09-30 | $46.06K derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-25 | $91.47K derived: sum of 2 quarters · filed 2014-11-25 | $127.83K derived: sum of 3 quarters · filed 2014-11-25 | $128.41K 10-K · filed 2014-11-25 | $129.86K 10-K · filed 2013-12-18 | ||||||||||||
| 2013-06-30 | $45.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-12 | $81.77K derived: sum of 2 quarters · filed 2014-08-12 | $82.34K 10-Q · filed 2014-08-12 | $112.36K derived: sum of 4 quarters · filed 2014-11-25 | $83.79K 10-Q · filed 2013-08-07 | ||||||||||||
| 2013-03-31 | $36.36K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-06 | $36.93K 10-Q · filed 2014-05-06 | $66.95K derived: sum of 3 quarters · filed 2014-11-25 | $40.04K derived: sum of 4 quarters · filed 2014-11-25 | $38.38K 10-Q · filed 2013-05-09 | ||||||||||||
| 2012-12-31 | $572.00 10-Q · filed 2014-02-04 | $30.59K derived: sum of 2 quarters · filed 2014-11-25 | $3.68K derived: sum of 3 quarters · filed 2014-11-25 | $6.18K derived: sum of 4 quarters · filed 2014-11-25 | $2.02K 10-Q · filed 2013-02-13 | ||||||||||||
| 2012-09-30 | $30.02K derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-25 | $3.10K derived: sum of 2 quarters · filed 2014-11-25 | $5.61K derived: sum of 3 quarters · filed 2014-11-25 | $9.39K 10-K · filed 2014-11-25 | $1.45K 10-K · filed 2012-12-28 | ||||||||||||
| 2012-06-30 | -$26.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-07 | -$24.42K derived: sum of 2 quarters · filed 2013-08-07 | -$20.63K 10-Q · filed 2013-08-07 | -$16.08K derived: sum of 4 quarters · filed 2013-08-07 | -$28.57K 10-Q · filed 2012-08-13 | ||||||||||||
| 2012-03-31 | $2.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-09 | $6.29K 10-Q · filed 2013-05-09 | $10.83K derived: sum of 3 quarters · filed 2013-05-09 | -$17.12K derived: sum of 4 quarters · filed 2013-05-09 | -$1.65K 10-Q · filed 2012-05-08 | ||||||||||||
| 2011-12-31 | $3.78K 10-Q · filed 2013-02-13 | $8.33K derived: sum of 2 quarters · filed 2013-02-13 | -$19.62K derived: sum of 3 quarters · filed 2013-02-13 | -$4.16K 10-Q · filed 2012-02-09 | |||||||||||||
| 2011-09-30 | $4.55K derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-28 | -$23.41K derived: sum of 2 quarters · filed 2012-12-28 | -$7.94K 10-K · filed 2012-12-28 | -$7.94K 10-Q · filed 2012-08-13 | |||||||||||||
| 2011-06-30 | -$27.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-13 | -$12.49K 10-Q · filed 2012-08-13 | -$12.49K 10-Q · filed 2011-08-08 | ||||||||||||||
| 2011-03-31 | $15.47K 10-Q · filed 2012-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |